- Home
- UTL vs EVMN Comparison
UTL vs EVMN Comparison
Compare UTL & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UTL | EVMN |
|---|---|---|
| Founded | 1984 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.9M | 825.5M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | UTL | EVMN |
|---|---|---|
| Price | $50.36 | $22.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $56.50 | $43.88 |
| AVG Volume (30 Days) | 81.9K | ★ 381.8K |
| Earning Date | 05-04-2026 | 06-11-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | ★ 1.37 | N/A |
| EPS | ★ 1.85 | N/A |
| Revenue | ★ $536,000,000.00 | N/A |
| Revenue This Year | $5.43 | N/A |
| Revenue Next Year | $4.22 | N/A |
| P/E Ratio | $27.54 | ★ N/A |
| Revenue Growth | ★ 8.33 | N/A |
| 52 Week Low | $45.11 | $13.89 |
| 52 Week High | $55.12 | $33.20 |
Technical Indicators
Market Signals| Indicator | UTL | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 41.43 | 46.84 |
| Support Level | $50.15 | $21.32 |
| Resistance Level | $50.77 | $23.08 |
| Average True Range (ATR) | 0.91 | 1.25 |
| MACD | 0.05 | 0.13 |
| Stochastic Oscillator | 23.49 | 51.43 |
Price Performance
Historical ComparisonAbout UTL UNITIL Corporation
Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.